HCPCS J2351 — Inj ocrelizumab 1mg hya-ocsq (2026 RVU Values)

HCPCS code J2351 (Inj ocrelizumab 1mg hya-ocsq) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.

Related references